ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth

Fund Overview

Fund Size

₹5,320 Cr

Expense Ratio

1.08%

ISIN

INF109KC1GH2

Minimum SIP

₹1,000

Exit Load

1.00%

Inception Date

12 Jul 2018

About this fund

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth is a Sector - Healthcare mutual fund schemes offered by ICICI Prudential Mutual Fund. This fund has been in existence for 6 years, 6 months and 8 days, having been launched on 12-Jul-18.
As of 17-Jan-25, it has a Net Asset Value (NAV) of ₹41.03, Assets Under Management (AUM) of 5320.29 Crores, and an expense ratio of 1.08%.

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth has given a CAGR return of 24.18% since inception.
The fund's asset allocation comprises around 98.07% in equities, 0.00% in debts, and 1.77% in cash & cash equivalents.
You can start investing in ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth with a SIP of ₹1000 or a Lumpsum investment of ₹5000.

Performance against Category Average

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.

1 Year

+38.61%

+30.47% (Cat Avg.)

3 Years

+23.87%

+18.36% (Cat Avg.)

5 Years

+30.00%

+25.79% (Cat Avg.)

Since Inception

+24.18%

— (Cat Avg.)

Portfolio Summaryas of 31st December 2024

Equity	₹5,217.78 Cr	98.07%
Others	₹102.51 Cr	1.93%

Top Holdings

All Holdings

Equity

Debt & Others

Name	Type	Amount	Holdings
Sun Pharmaceuticals Industries Ltd	Equity	₹735.77 Cr	13.83%
Cipla Ltd	Equity	₹493.63 Cr	9.28%
Dr Reddy's Laboratories Ltd	Equity	₹475.1 Cr	8.93%
Divi's Laboratories Ltd	Equity	₹295.85 Cr	5.56%
Aurobindo Pharma Ltd	Equity	₹268.88 Cr	5.05%
Lupin Ltd	Equity	₹248.66 Cr	4.67%
Alkem Laboratories Ltd	Equity	₹211.85 Cr	3.98%
Gland Pharma Ltd	Equity	₹198.29 Cr	3.73%
Mankind Pharma Ltd	Equity	₹171.45 Cr	3.22%
Zydus Lifesciences Ltd	Equity	₹157.31 Cr	2.96%
Apollo Hospitals Enterprise Ltd	Equity	₹135.31 Cr	2.54%
Pfizer Ltd	Equity	₹114.73 Cr	2.16%
Biocon Ltd	Equity	₹104.88 Cr	1.97%
Treps	Cash - Repurchase Agreement	₹102.21 Cr	1.92%
AstraZeneca Pharma India Ltd	Equity	₹94 Cr	1.77%
SBI Life Insurance Co Ltd	Equity	₹90.16 Cr	1.69%
Windlas Biotech Ltd	Equity	₹89.29 Cr	1.68%
Syngene International Ltd	Equity	₹86.15 Cr	1.62%
Medplus Health Services Ltd	Equity	₹82.83 Cr	1.56%
Shilpa Medicare Ltd	Equity	₹78.54 Cr	1.48%
Senores Pharmaceuticals Ltd	Equity	₹72.71 Cr	1.37%
Medi Assist Healthcare Services Ltd	Equity	₹70.75 Cr	1.33%
HealthCare Global Enterprises Ltd	Equity	₹69.48 Cr	1.31%
Aster DM Healthcare Ltd Ordinary Shares	Equity	₹69.44 Cr	1.31%
Thyrocare Technologies Ltd	Equity	₹68.92 Cr	1.30%
Glenmark Pharmaceuticals Ltd	Equity	₹60.96 Cr	1.15%
FDC Ltd	Equity	₹59.82 Cr	1.12%
J.B. Chemicals & Pharmaceuticals Ltd	Equity	₹57.87 Cr	1.09%
Fortis Healthcare Ltd	Equity	₹55.82 Cr	1.05%
Aarti Drugs Ltd	Equity	₹51.77 Cr	0.97%
Yatharth Hospital and Trauma Care Services Ltd	Equity	₹50.36 Cr	0.95%
Fine Organic Industries Ltd Ordinary Shares	Equity	₹48.59 Cr	0.91%
Blue Jet Healthcare Ltd	Equity	₹48.11 Cr	0.90%
Alivus Life Sciences Ltd	Equity	₹47.32 Cr	0.89%
Emcure Pharmaceuticals Ltd	Equity	₹43.07 Cr	0.81%
Star Health and Allied Insurance Co Ltd	Equity	₹42.32 Cr	0.80%
Procter & Gamble Health Ltd	Equity	₹40.86 Cr	0.77%
Sanofi Consumer Healthcare India Ltd	Equity	₹40.18 Cr	0.76%
Alembic Pharmaceuticals Ltd	Equity	₹26.19 Cr	0.49%
Sun Pharma Advanced Research Co Ltd	Equity	₹25.12 Cr	0.47%
Unichem Laboratories Ltd	Equity	₹20.13 Cr	0.38%
Krsnaa Diagnostics Ltd	Equity	₹15.31 Cr	0.29%
Cash Margin - Derivatives	Other Assets And Liabilities	₹8.41 Cr	0.16%
Net Current Assets	Cash	₹-8.11 Cr	0.15%

Allocation By Market Cap (Equity)

Other Allocation

Equity Sector

Debt & Others

Sector	Amount	Holdings
Healthcare	₹5,036.71 Cr	94.67%
Financial Services	₹132.48 Cr	2.49%
Basic Materials	₹48.59 Cr	0.91%

Risk & Performance Ratios

Fund Managers

Dharmesh Kakkad

Since May 2020

Sharmila D’mello

Since July 2022

Additional Scheme Detailsas of 31st December 2024

ISIN

INF109KC1GH2

Expense Ratio

1.08%

Exit Load

1.00%

Fund Size

₹5,320 Cr

Age

6 years 6 months

Lumpsum Minimum

₹5,000

Fund Status

Open Ended Investment Company

Benchmark

BSE Healthcare TR INR

Investment Objective

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.

Tax Treatment

Capital Gains Taxation:

Dividend Taxation:

Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Similar Sector - Healthcare Funds

Fund name	Expense Ratio	Exit Load	Fund size	1Y
Motilal Oswal S&P BSE Healthcare ETF Very High Risk	0.2%	-	₹31.91 Cr	32.1%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth Very High Risk	0.9%	1.0%	₹890.33 Cr	25.7%
Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth Very High Risk	2.3%	1.0%	₹890.33 Cr	24.0%
Aditya Birla Sun Life Nifty Healthcare ETF Very High Risk	0.2%	-	₹44.16 Cr	30.6%
ITI Pharma and Healthcare Fund Direct Growth Very High Risk	0.5%	1.0%	₹230.79 Cr	32.2%
ITI Pharma and Healthcare Fund Regular Growth Very High Risk	2.4%	1.0%	₹230.79 Cr	29.8%
Mirae Asset Healthcare Fund Direct Growth Very High Risk	0.5%	1.0%	₹2863.52 Cr	31.1%
Mirae Asset Healthcare Fund Regular Growth Very High Risk	1.9%	1.0%	₹2863.52 Cr	29.2%
Nippon India Nifty Pharma ETF Very High Risk	0.2%	-	₹922.81 Cr	29.1%
Axis NIFTY Healthcare ETF Very High Risk	0.3%	-	₹20.52 Cr	29.7%

About the AMC

ICICI Prudential Mutual Fund

+91 22 26428000

https://www.icicipruamc.com/

Total AUM

₹8,91,403 Cr

Address

3rd Floor, Hallmark Business Plaza, Mumbai, 400 051

Other Funds by ICICI Prudential Mutual Fund

Fund name	Expense Ratio	Exit Load	Fund size	1Y
ICICI Prudential Nifty50 Value 20 Index Fund Direct Growth Very High Risk	0.3%	0.0%	₹87.54 Cr	-
ICICI Prudential Fixed Maturity Plan Series 88 182 Days Plan J Direct Growth Moderate Risk	-	-	-	-
ICICI Prudential Fixed Maturity Plan Series 88 125 Days Plan H Direct Growth Low to Moderate Risk	-	-	-	-
ICICI Prudential Fixed Maturity Plan Series 88 93 Days Plan P Direct Growth Low to Moderate Risk	-	-	-	-
ICICI Prudential Fixed Maturity Plan Series 88 1199 Days Plan Q Direct Growth Low to Moderate Risk	-	-	-	-
ICICI Prudential Fixed Maturity Plan Series 88 1858 Days Plan D Direct Growth Moderate Risk	-	0.0%	-	-
ICICI Prudential Fixed Maturity Plan Series 88 1226 Days Plan F Direct Growth Low to Moderate Risk	-	-	₹128.85 Cr	7.7%
ICICI Prudential Long Term Wealth Enhancement Fund Direct Growth Very High Risk	1.0%	0.0%	₹41.30 Cr	21.7%
ICICI Prudential Fixed Maturity Plan Series 88 1828 Days Plan A Direct Growth Moderate Risk	-	-	-	-
ICICI Prudential Fixed Maturity Plan Series 88 1833 Days Plan C Direct Growth Moderate Risk	-	-	-	-
ICICI Prudential Fixed Maturity Plan Series 88 1192 Days Plan R Direct Growth Low to Moderate Risk	-	-	-	-
ICICI Prudential Fixed Maturity Plan Series 88 95 Days Plan B Direct Growth Moderately High risk	-	-	-	-
ICICI Prudential Fixed Maturity Plan Series 88 1303 Days Plan S Direct Growth Low to Moderate Risk	-	0.0%	₹61.98 Cr	8.2%
ICICI Prudential Fixed Maturity Plan Series 88 226 Days Plan E Direct Growth Moderate Risk	-	0.0%	-	-
ICICI Prudential Thematic Advantage Fund (FOF) Direct Growth Very High Risk	1.2%	1.0%	₹2198.75 Cr	21.1%
ICICI Prudential Floating Interest Fund Direct Growth Moderate Risk	0.6%	0.0%	₹7776.88 Cr	8.8%
ICICI Prudential Gilt Fund Direct Growth Moderate Risk	0.6%	0.0%	₹6810.77 Cr	8.6%
ICICI Prudential All Seasons Bond Fund Direct Growth Moderate Risk	0.6%	0.0%	₹13407.28 Cr	8.9%
ICICI Prudential Long Term Bond Fund Direct Growth Moderate Risk	0.4%	0.0%	₹1033.69 Cr	10.3%
ICICI Prudential Liquid Fund Direct Growth Moderate Risk	0.2%	0.0%	₹49652.96 Cr	7.4%
ICICI Prudential Innovation Fund Direct Growth Very High Risk	0.7%	1.0%	₹6392.08 Cr	25.9%
ICICI Prudential Global Stable Equity Fund (FOF) Direct Growth Very High Risk	1.7%	1.0%	₹116.57 Cr	9.4%
ICICI Prudential Bond Fund Direct Growth Moderate Risk	0.6%	0.0%	₹3085.06 Cr	8.8%
ICICI Prudential Smallcap Fund Direct Growth Very High Risk	0.8%	1.0%	₹8257.98 Cr	11.6%
ICICI Prudential Midcap Fund Direct Growth Very High Risk	1.1%	1.0%	₹6339.07 Cr	20.2%
ICICI Prudential Infrastructure Fund Direct Growth Very High Risk	1.2%	1.0%	₹6910.52 Cr	22.0%
ICICI Prudential Nifty 50 Index Fund Direct Growth Very High Risk	0.2%	0.0%	₹11875.12 Cr	8.6%
ICICI Prudential Regular Savings Fund Direct Growth High Risk	0.9%	1.0%	₹3172.75 Cr	11.7%
ICICI Prudential Money Market Fund Direct Growth Moderate Risk	0.2%	0.0%	₹25286.22 Cr	7.8%
ICICI Prudential Nifty Next 50 Index Direct Growth Very High Risk	0.3%	0.0%	₹6893.99 Cr	20.1%
ICICI Prudential Regular Gold Savings (FOF) Direct Growth High Risk	0.6%	1.0%	₹1385.31 Cr	26.6%
ICICI Prudential Credit Risk Fund Direct Growth High Risk	0.8%	1.0%	₹6287.09 Cr	8.9%
ICICI Prudential Large & Mid Cap Fund Direct Growth Very High Risk	0.8%	1.0%	₹17679.54 Cr	20.2%
ICICI Pru Multicap Fund Direct Growth Very High Risk	1.0%	1.0%	₹14019.22 Cr	18.0%
ICICI Prudential Short Term Fund Direct Growth Moderate Risk	0.5%	0.0%	₹19700.32 Cr	8.4%
ICICI Prudential US Bluechip Equity Fund Direct Growth Very High Risk	1.2%	1.0%	₹3228.15 Cr	16.7%
ICICI Prudential Corporate Bond Fund Direct Growth Moderate Risk	0.3%	0.0%	₹29117.59 Cr	8.2%
ICICI Prudential Exports and Services Fund Direct Growth Very High Risk	1.7%	1.0%	₹1433.05 Cr	20.4%
ICICI Prudential Long Term Equity Fund ( Tax Saving) Direct Growth Very High Risk	1.1%	0.0%	₹13846.63 Cr	14.9%
ICICI Prudential Technology Direct Growth Very High Risk	1.0%	1.0%	₹14274.58 Cr	19.5%
ICICI Prudential Income Optimizer Fund (FOF) Direct Growth Moderate Risk	1.1%	1.0%	₹268.83 Cr	12.4%
ICICI Prudential Flexicap Fund Direct Growth Very High Risk	0.8%	1.0%	₹16716.76 Cr	18.9%
ICICI Prudential Equity Savings Fund Direct Growth Moderate Risk	0.5%	0.0%	₹12554.90 Cr	8.4%
ICICI Prudential Retirement Fund Hybrid Aggressive Plan Direct Growth Very High Risk	0.6%	0.0%	₹747.48 Cr	18.6%
ICICI Prudential Retirement Fund Pure Equity Plan Direct Growth Very High Risk	0.7%	0.0%	₹1063.22 Cr	20.4%
ICICI Prudential Retirement Fund Hybrid Conservative Plan Direct Growth Moderately High risk	0.9%	0.0%	₹78.10 Cr	9.2%
ICICI Prudential Retirement Fund Pure Debt Plan Direct Growth Moderate Risk	1.2%	0.0%	₹107.46 Cr	8.3%
ICICI Prudential India Opportunities Fund Direct Growth Very High Risk	0.7%	1.0%	₹24552.50 Cr	20.6%
ICICI Prudential Passive Multi-Asset Fund of Funds Direct Growth High Risk	0.5%	1.0%	₹1094.57 Cr	12.4%
ICICI Prudential Banking and PSU Debt Fund Direct Growth Moderate Risk	0.4%	0.0%	₹9859.55 Cr	8.2%

Risk Level

Your principal amount will be at Very High Risk

Unlock Expert Insights!

Maximise Returns with our Wealth Monitor App. Try it now!

Still got questions?
We're here to help.

What is the current NAV of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth?

The NAV of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth, as of 17-Jan-2025, is ₹41.03.

What are the returns of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth?

The fund has generated 38.61% over the last 1 year and 23.87% over the last 3 years. However, this does not guarantee that the fund will perform similarly in the future.

What is the portfolio composition of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth?

The fund's allocation of assets is distributed as 98.07% in equities, 0.00% in bonds, and 1.77% in cash and cash equivalents.

Who manages the ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth?

The fund managers responsible for ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth are:-

Dharmesh Kakkad
Sharmila D’mello

Disclaimer: Mutual Fund investments are subject to market risks, read all scheme-related documents carefully. The NAVs of the schemes may go up or down depending upon the factors and forces affecting the securities market including the fluctuations in the interest rates. The past performance of the mutual funds is not necessarily indicative of the future performance of the schemes. Investors are requested to review the prospectus carefully and obtain expert professional advice with regard to specific legal, tax and financial implications of the investment/participation in the scheme.

;

Fund Overview

Fund Size

₹5,320 Cr

Expense Ratio

1.08%

ISIN

INF109KC1GH2

Minimum SIP

₹1,000

Exit Load

1.00%

Inception Date

12 Jul 2018

Risk Level

Your principal amount will be at Very High Risk